- |||||||||| Trial completion: T-cell Response-Flu Risk in Older Adults (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=850, Completed, Active, not recruiting --> Completed | Trial completion date: Nov 2019 --> Aug 2017 Recruiting --> Completed
- |||||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Enrollment change: FluEMIST: FluMist in Egg Allergic Patients (clinicaltrials.gov) - Oct 3, 2018 P1/2, N=17, Completed, N=800 --> 0 Recruiting --> Completed | N=200 --> 17
- |||||||||| Trial completion: Efficacy of Sambucol in the Treatment of Influenza (clinicaltrials.gov) - Jun 12, 2018
P4, N=100, Completed, Trial completion date: Nov 2017 --> Nov 2019 | Trial primary completion date: Nov 2017 --> Nov 2019 Active, not recruiting --> Completed
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Two-site Intradermal Influenza Vaccination in Elderly (clinicaltrials.gov) - Apr 6, 2018
P=N/A, N=180, Completed, Trial completion date: May 2018 --> May 2019 | Trial primary completion date: May 2018 --> May 2019 Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Dec 2018 --> Apr 2018
- |||||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Phase classification, Enrollment change: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Apr 4, 2018 P, N=62, Completed, Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Dec 2018 --> Apr 2018 Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62
- |||||||||| oseltamivir / Generic mfg.
Phase classification, Enrollment change, Trial withdrawal: An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study. (clinicaltrials.gov) - Mar 19, 2018 P4, N=0, Withdrawn, Phase classification: P=N/A --> P | N=2400 --> 4197 Phase classification: P1 --> P4 | N=100 --> 0 | Not yet recruiting --> Withdrawn
- |||||||||| Trial completion date, Trial primary completion date: ResPECT: The Respiratory Protection Effectiveness Clinical Trial (clinicaltrials.gov) - Mar 5, 2018
P=N/A, N=1600, Active, not recruiting, Phase classification: P1 --> P4 | N=100 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Dec 2017 --> Jan 2019 | Trial completion date: Dec 2017 --> Jan 2019
- |||||||||| Fluzone (influenza vaccine) / Sanofi
Trial completion: Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) - Jan 31, 2018 P4, N=103, Completed, Phase classification: P4 --> P=N/A Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Influenza Vaccine Post Allogeneic Transplant (clinicaltrials.gov) - Dec 28, 2017
P=N/A, N=68, Terminated, Trial primary completion date: Nov 2018 --> Feb 2017 Trial primary completion date: Jan 2012 --> Jun 2011
- |||||||||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD), Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial primary completion date: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (clinicaltrials.gov) - Dec 26, 2017 P3, N=2808, Completed, Trial primary completion date: Jan 2012 --> Jun 2011 Trial primary completion date: Jul 2013 --> Dec 2012
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Respiratory Virus Outpatient Study (FLU 002 Plus) (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=11719, Completed, Recruiting --> Completed | N=330 --> 168 Recruiting --> Completed | N=5000 --> 11719 | Trial primary completion date: Sep 2017 --> May 2017
- |||||||||| Enrollment closed, Trial primary completion date: Use of Probiotics to Prevent Influenza (clinicaltrials.gov) - Aug 4, 2017
P=N/A, N=1440, Active, not recruiting, Recruiting --> Completed | N=5000 --> 11719 | Trial primary completion date: Sep 2017 --> May 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Aug 2017
|